Trial Profile
Duration of Motor Response After Administration of Experimental Levodopa/Carbidopa/Entacapone Treatment Regimens Compared to Standard Treatment (Stalevo); a Randomised, Double-blind, Crossover, Multicentre, Single Dose Study in Patients With Parkinson's Disease and Wearing-off Symptoms.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa/entacapone (Primary) ; Carbidopa; Entacapone; Levodopa
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms PARTEST
- Sponsors Orion Pharma
- 09 Sep 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 09 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.